Calling it a 'transformational deal' that will expand its presence in the all-important US market, Spain’s Almirall SA has bought Allergan PLC’s US dermatology portfolio in a transaction worth up to $650m.
The purchase, which is expected to close in the fourth quarter, includes an upfront cash payment of $550m and a...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
